These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33522964)

  • 21. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.
    Shoji J; Ohashi Y; Fukushima A; Miyazaki D; Uchio E; Takamura E; Fujishima H; Namba K; Kumagai N; Ebihara N; Okamoto S
    Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
    Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
    Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical cyclosporine for atopic keratoconjunctivitis.
    González-López JJ; López-Alcalde J; Morcillo Laiz R; Fernández Buenaga R; Rebolleda Fernández G
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009078. PubMed ID: 22972132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis.
    Heikal MA; Soliman TT; Abousaif WS; Shebl AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):353-361. PubMed ID: 34453603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atopic keratoconjunctivitis with corneal ulcer. Case report.
    Zemba M; Burcea M; Camburu G
    Rom J Ophthalmol; 2016; 60(3):200-206. PubMed ID: 29450349
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
    Ueta M; Sotozono C; Koga A; Yokoi N; Kinoshita S
    Allergol Int; 2014 Mar; 63(1):75-81. PubMed ID: 24457813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
    Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis.
    Al-Amri AM
    Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
    Leonardi A; Jose PJ; Zhan H; Calder VL
    Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis.
    Saha BC; Kumari R; Ambasta A
    Ther Adv Ophthalmol; 2023; 15():25158414231173532. PubMed ID: 37255622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis.
    Shoughy SS; Jaroudi MO; Tabbara KF
    Clin Ophthalmol; 2016; 10():643-7. PubMed ID: 27103784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Follow-up study on patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment].
    Harada N; Inada N; Ishimori A; Shoji J; Sawa M
    Nippon Ganka Gakkai Zasshi; 2014 Apr; 118(4):378-84. PubMed ID: 24864437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis.
    Albarry MA; Parekh M; Ferrari S; Eltahir HM; Shehata AM; Shaker MA; Elbadawy HM
    Front Pharmacol; 2022; 13():798998. PubMed ID: 35401178
    [No Abstract]   [Full Text] [Related]  

  • 36. Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review.
    Li J; Luo X; Ke H; Liang L
    Pediatrics; 2018 Apr; 141(Suppl 5):S470-S474. PubMed ID: 29610174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis.
    Uchio E; Ono SY; Ikezawa Z; Ohno S
    Clin Exp Allergy; 2000 Jan; 30(1):103-9. PubMed ID: 10606937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of Staphylococcal enterotoxin in atopic keratoconjunctivitis and corneal ulceration.
    Fujishima H; Okada N; Dogru M; Baba F; Tomita M; Abe J; Matsumoto K; Saito H
    Allergy; 2012 Jun; 67(6):799-803. PubMed ID: 22486642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
    Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
    Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Clinical Outcome of Tacrolimus Skin Ointment (0.03%) for the Treatment of Vernal Keratoconjunctivitis: A Quasi-Experimental Study.
    Ali W; Alam Khan S; Ullah Khan F; Khan S; Khan WA; Zafar R; Moqeet MA
    Cureus; 2023 Dec; 15(12):e50579. PubMed ID: 38226116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.